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Purpose: To follow the changes in the electroretinograms (ERGs) in a patient with primary 
intraocular lymphoma (PIOL) who had a complete remission after chemotherapy.
Methods: ERGs were recorded in a 41-year-old woman with PIOL during and after complete 
remission with chemotherapy. The patient was diagnosed with PIOL from both the ocular signs 
and the medical history of cranial lymphoma.
Results: The ERGs were depressed in the subject. The amplitudes of the bright white flash 
b-waves were smaller than the a-waves, resulting in a “negative type” ERG. Six weeks after the 
beginning of chemotherapy, the ocular changes had resolved, and the ERGs, although not of the 
“negative type”, still showed signs that the amplitude had not returned to normal levels.
Conclusion: The negative type ERGs indicated that the inner retina had been damaged to a 
greater extent than the outer retina. In the convalescent stage, when the ocular manifestations 
were resolved, the ERGs were still not fully recovered. Although only one case was studied, 
we suggest that ERGs can be used to evaluate and follow patients with a PIOL.
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Introduction
A primary intraocular lymphoma (PIOL) is a subtype of primary non-Hodgkin’s 
lymphomas of the central nervous system in which the retina, vitreous, and/or optic 
nerve head may be involved.1–3 Patients with a PIOL typically present with a form of 
uveitis and vitritis that is unresponsive to corticosteroid therapy, thus the so-called 
uveitis masquerade syndrome. This can occur together with, or independently of, a 
primary cerebral nervous system lymphoma. The disease has a poor prognosis, and 
patients normally die as a result the growth of the cerebral lymphoma with a mean 
survival of 20 months from the diagnosis of the ocular disorder.4
As best we know, electroretinography (ERG) has not been used to follow the 
changes in retinal function during the course of PIOL. We present the changes in the 
ERGs during and after a complete remission of PIOL with chemotherapy.
Case report
The patient, a 41-year-old woman, had been diagnosed with a primary intracranial 
malignant lymphoma (non-Hodgkins, diffuse medium-sized B cell lymphoma) for 
three years. She presented with a 3-week history of blurred vision and photophobia, 
primarily in her right eye. Her best-corrected visual acuities were 20/60 OD and 20/20 
OS. The intraocular pressure was normal in both eyes. Slit-lamp examination showed 
mild vitritis in the right eye, and ophthalmoscopy showed no abnormalities.Clinical Ophthalmology 2010:4 302
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After 3 weeks of observation the right fundus had 
  developed whitish exudates, massive subretinal infiltration 
from a macular lesion, and slight swelling of the optic disc. 
Cells were detected in the anterior chamber, but the fundus 
of the left eye was normal (Figure 1). The Goldmann visual 
field of the right eye had a dense central relative scotoma, 
but was almost normal in the left eye (Figure 2).
Full-field ERGs were recorded according to International 
Society for Clinical Electrophysiology of Vision (ISCEV) 
standards.5 The scotopic, bright white, cone, and 30 Hz flicker 
ERGs 3 weeks after the initial visit are shown in Figure 3. The 
amplitudes of the different ERG components were reduced 
in both eyes, but to a greater extent in the right eye. The 
amplitude of the bright white flash b-waves was distinctly 
reduced, and was smaller than the a-waves, resulting in the 
“negative type” ERG in both eyes. This indicated that the 
functional depression was greater in the inner retina than 
the outer retina.6
Focal macular ERGs were recorded to assess macular 
  function as described in Miyake et al.7 The ERG from the 
right eye was almost nonrecordable, and that of left eye 
was about one-half the normal amplitude (Figure 3; Focal 
macular ERGs).
Because of the rapid decrease in the visual acuity of the right 
eye to 20/600, and the increasing retinal infiltration and exuda-
tions since the previous examination, diagnostic vitrectomy 
was performed (Figure 4). Cytological examination of the 
vitreal specimen did not show any abnormal lymphocytes or 
monocytes, in addition to which flow cytometry did not show 
monoclonality. The cytokine analysis was negative without a 
specific increase in the IL10/IL6 ratio. Although the results 
of the cytological examinations were negative, a primary 
intraocular lymphoma was strongly suspected.
Eight weeks after the first visit, chemotherapy with 
cyclophosphamide, cytosine arabinoside, etoposide, and 
dexamethasone was started. Four days after the treatment, 
the visual symptoms and ophthalmoscopic appearance of the 
fundus improved. Six weeks after beginning chemotherapy, 
her best-corrected visual acuity improved to 20/20 in both 
eyes. The ocular lesions were completely resolved, leaving 
atrophic pigmentary changes (Figure 5). A relative central 
scotoma still remained in the right eye, but the visual field 
Figure 1 Fundus photograph of the right A) and the left eyes B). The right fundus shows whitish exudates, massive subretinal infiltration under the macular lesion, and slight 
disc swelling. The left fundus is normal. Fluorescein angiography of the right C) and left eyes D) Slight leakage of fluorescein can be seen on the right optic disc. The left eye is 
normal. Optical coherence tomography of the macular area of the right E) and left eye F). Massive subretinal infiltration is present in the right eye. The left eye is normal.Clinical Ophthalmology 2010:4 303
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Figure 2 Goldmann perimetry showing a central scotoma in the right eye. The visual field of left eye is normal.
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Figure 3 Full-field ERGs (rod, bright white, cone and 30 Hz flicker) recorded according to International Society for Clinical Electrophysiology of Vision (ISCEV) standards. 
Compared to the normal erGs, the amplitudes of all components were reduced especially in the right eye. Focal macular erGs elicited by a 15 degree stimulus spot were 
recorded from both eyes (bottom row).   A marked reduction of amplitude can be seen in the right eye.Clinical Ophthalmology 2010:4 304
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Figure 4 Fundus photograph after vitrectomy of the right eye. The retinal infiltrates and exudates have progressed in the right eye within one week since the previous 
examination. The left eye fundus had no abnormality.
Figure 5 Fundus photography of the right A) and the left eye B) one month after chemotherapy.   The ocular lesions have completely resolved leaving atrophic pigmentary changes. 
Optical coherence tomography of the macular area of the right C) and the left eye D) shows that the massive subretinal infiltration of the right eye has disappeared.
sensitivity had improved. The cells in the anterior chamber 
of the left eye had also disappeared.
Although the rod and cone components of the full-field ERGs 
had improved after chemotherapy, the amplitudes had still not 
reached normal limits (Figure 6). The recovery of the b-wave 
was greater than that of the a-wave in the bright flash ERG, and 
so the waveform was not of the “negative type” at this point.
Three years after the therapy, the patient had no evidence 
of systemic disease or recurrence of the PIOL. The ERGs 
were greatly improved but the amplitudes had still not 
reached the normal range.
Discussion
We have followed a patient with a PIOL by electroretinography, 
who went into complete remission after chemotherapy. We 
found that the bright flash ERGs were the negative-type ERGs 
before chemotherapy. These ERG findings suggest that the 
inner retina was damaged more than the outer retina. As a 
differential diagnosis, we suspected endophthalmitis and 
uveitis, especially Beçhet’s disease. However, from the history 
of intracranial malignant lymphoma, and the clinical signs, 
we diagnosed the patient as having a PIOL, even though the 
vitreous biopsy did not detect any malignant cells or a change Clinical Ophthalmology 2010:4 305
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in the IL-10/IL-6 ratio. It is known that the interpretation of 
vitreous specimens is sometimes difficult, and more than 40% 
of vitrectomy specimens may be nondiagnostic.8,3
After chemotherapy, the b-wave recovered more quickly 
than the a-wave. These results indicate that the inner retinal 
damage was transient, and may have resulted from secondary 
inflammation due to the presence of tumor cells. In the 
convalescent stage, when the ocular manifestations were 
resolved, both full-field and focal macular ERGs were still 
not fully recovered.
Earlier histopathological studies of PIOL’s have 
  mentioned an infiltration of malignant lymphoma cells into 
the subretinal space, which would be detected as whitish 
exudates, and could also lead to damage to the retina.9,10 In 
our case, a marked prolongation of the focal macular ERG 
in the right eye may have been as a result of photoreceptor 
damage caused by just such subretinal infiltration.
Conclusion
In conclusion, we recorded ERGs from a patient whose 
ocular findings and history indicated that she had PIOL. 
The full-field ERGs were reduced in the right eye, showing 
a the negative-type ERG. After chemotherapy, there was a 
recovery in both the ocular signs and the ERGs. Although our 
  conclusions are based on only one case, we recommend that 
ERGs be used to diagnose and follow patients with a PIOL.
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